Effect of Maxillary Third Molar Extraction vs. Non-extraction on Distalization of First Molars in a Group of Adolescent Patients
Launched by FUTURE UNIVERSITY IN EGYPT · Dec 8, 2022
Trial Information
Current as of June 09, 2025
Completed
Keywords
ClinConnect Summary
Maxillary molar distalization is one of the non-extraction modalities for treating class II malocclusion. When distalizing maxillary molars In adults, it is not a problem to extract fully erupted third molars, and it may even be suggested that the extraction site may accommodate distalization. On the contrary, adolescents usually have unerupted third molars with partially formed roots, rendering the surgical extraction more difficult and traumatic. The necessity of surgically extracting upper third molar buds before distalization remains questionable. Therefore, this study was conducted to ...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Adolescent patients aged 16-19 years
- • skeletal Class I
- • bilateral Class II molar relationship. defined by at least an end-to-end molar relationship.
- • normal vertical growth pattern.
- • full permanent dentition with unerupted upper third molars.
- Exclusion Criteria:
- • skeletal Class II or Class III relationship.
- • past orthodontic treatment.
- • poor oral hygiene.
- • Increased vertical dimension.
About Future University In Egypt
Future University in Egypt is a leading academic institution dedicated to advancing medical research and education. As a clinical trial sponsor, the university focuses on innovative studies that aim to enhance healthcare outcomes and address pressing medical challenges. With a commitment to ethical standards and scientific rigor, Future University collaborates with healthcare professionals and researchers to facilitate evidence-based practices and contribute to the global body of medical knowledge. Its strategic initiatives aim to foster a culture of research excellence, ultimately benefiting both local and international communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Yehya Mostafa, Professor and Chairman
Study Director
Future University in Egypt
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials